What's New

Updated Inclusion Exclusion Criteria

App Description

This mobile application was created to facilitate enrollment into the ATACH-II Clinical Trial. ATACH-II is a five-year clinical trial designed to determine the efficacy of early, intensive antihypertensive treatment in stroke patients.

The primary hypothesis of this trial is that treating hemorrhagic stoke survivors with intensive blood pressure reduction therapy will reduce the proportion of death and disability at 3 months by 10% or greater compared with the group treated with the standard blood pressure reduction therapy.

iPhone Screenshots

(click to enlarge)

ATACH-2 screenshot 1 ATACH-2 screenshot 2 ATACH-2 screenshot 3

App Changes

  • June 09, 2014 Initial release

Other Apps From MentorMate, Inc.

MigraineMate AmmoBook Clear-III Mobile Business Mobile Assessment Tool MobCon BG MobCon MobCon Digital Health Star Tribune Midwest Retail Strategies Conference night.bg